The role of family physicians in the diagnosis, prevention and treatment of chronic venous insuffciency.

Prof. O.M. Korzh. Kharkiv Medical Academy of Postgraduate Education.

Chronic venous insufficiency (CVI) is the most common of peripheral vascular disease, and, at the same time refers to the problems in the medical environment which seldom raised. Significant role in the diagnosis, treatment strategy, and the subsequent management of patients with CVI is given to general practitioners, family doctors. Addressing CVI currently equires integrated application of  medical tactics, including both conservative treatment and surgical procedures to include compression therapy, physiotherapy and rehabilitation treatment. Basis of medical treatment CVI is phlebotropic drugs.

Korzh OM. [The role of family physicians in the diagnosis, prevention and treatment of chronic venous insufficiency]. Shidnoevr. z. vnutr. simejnoi med. 2016;1:82-86. Russian.
http://dx.doi.org/10.15407/internalmed2016.01.082

Download.PDF

1. Savelev VS, Gologorskii VA, Kirienko AI, authors; Savelev VS, editor. Flebologiia: Rukovodstvo dlia vrachei. [Phlebology. Guide for doctors]. M.: Meditsina; 2001. 641 p. Russian.
2. Shevchenko IL, Stoiko IM, Lytkina MI, editors. Osnovy klinicheskoi flebologii. [Bases of clinical phlebology]. M.: Meditsina; 2005. 197—213 p. Russian
3. Pokrovskij AV. Klinicheskaia angiologiia. Rukovodstvo dlia vrachei [Clinical angiology. Guide for doctors]. M.: Meditsina; 2004; 2: 788 — 809 p. Russian
4. Kiiashko VA. Konservativnoe lechenie khronicheskoi venoznoi nedostatochnosti. [Conservative treatment of chronic venous insufficiency]. Russkii meditsinskii zhurnal. 2002; 11 (26): 1214—1219. Russian
5. Bogachev VI. Sistemnaia farmakoterapiia khronicheskoi venoznoi nedostatochnosti nizhnikh konechnostei. Sovremennoe sostoianie voprosa. [Systemic pharmacotherapy of chronic venous insufficiency of lower extremities. Modern state of the question]. Russkii meditsinskii zhurnal. 2004; 12 (17): 3—6. Russian
6. Manthey JA. [Biological properties of flavonoids pertaining to inflammation]. Microcirculation. 2000; 7: S29—S34. English
http://dx.doi.org/10.1111/j.1549-8719.2000.tb00148.x
7. Anderson FJ, Spencer FA. [Risk Factors for Venous Thromboembolism ]. Circulation. 2003; 107: 1—9. English
http://dx.doi.org/10.1161/01.CIR.0000078469.07362.E6
8. Maksimovic ZV, Maksimovic M, Jadranin D. [Medicamental treatment of chronic venous insufficiency using semisynthetic diosmin – a prospective study ]. Acta Chir Iugosl. 2008; 55: 53—59. English
http://dx.doi.org/10.2298/ACI0804053M
9. Jantet G. [Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assessment and quality of life improvement with micronized flavonoids]. Angiology. 2002; 53: 245—256. English
http://dx.doi.org/10.1177/000331970205300301
10. Jawien A. [The influence of environmental factors in chronic venous insufficiency]. Angiology. 2003; 54(1): 19—31. English
http://dx.doi.org/10.1177/000331970305400104
11. Perrin M, Ramelet AA. [Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions]. Eur. J. Vasc. Endovasc. Surg. 2011; 41: 117—125. English
http://dx.doi.org/10.1016/j.ejvs.2010.09.025
12. Allaert FA. [Meta-analysis of the impact of the principal venoactive drugs agents on malleolar venous edema ]. Int. Angiol. 2012; 31: 310—315. English